Showing results (101-110 of 389) with videos related to

Sort By:
Pageof 39
Lung Cancer (Amsterdam, Netherlands)|April 28, 2019
Clinical significance of monitoring EGFR mutation in plasma using multiplexed digital PCR in EGFR mutated patients treated with afatinib (West Japan Oncology Group 8114LTR study)Hiroaki Akamatsu, Yasuhiro Koh, Isamu Okamoto, et al.
Cancer Chemotherapy and Pharmacology|May 30, 2009
Phase I clinical and pharmacokinetic study of the glucose-conjugated cytotoxic agent D-19575 (glufosfamide) in patients with solid tumorsToshio Shimizu, Isamu Okamoto, Kenji Tamura, et al.
Scientific Reports|July 24, 2021
Prognostic significance of pre-treatment ALBI grade in advanced non-small cell lung cancer receiving immune checkpoint therapyRyosuke Matsukane, Hiroyuki Watanabe, Kojiro Hata, et al.
Thoracic Cancer|November 16, 2022
Phase II study of durvalumab (MEDI 4736) plus carboplatin and etoposide in elderly patients with extensive stage small cell lung cancer: Study protocol of turtle study (LOGIK 2003)Hidenobu Ishii, Koichi Azuma, Takayuki Shimose, et al.
Thoracic Cancer|June 30, 2022
Erlotinib with or without bevacizumab as a first-line therapy for patients with advanced nonsquamous epidermal growth factor receptor-positive non-small cell lung cancer: Exploratory subgroup analyses from the phase II JO25567 studyYukio Hosomi, Takashi Seto, Makoto Nishio, et al.
Cancer Research|December 17, 2010
Role of survivin in EGFR inhibitor-induced apoptosis in non-small cell lung cancers positive for EGFR mutationsKunio Okamoto, Isamu Okamoto, Wataru Okamoto, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 11, 2016
Characteristics of Smoking Patients with Lung Cancer with Emphysematous BullaeEiji Iwama, Isamu Okamoto, Hidetake Yabuuchi, et al.
Molecular Cancer Therapeutics|November 15, 2011
Overcoming erlotinib resistance in EGFR mutation-positive non-small cell lung cancer cells by targeting survivinKunio Okamoto, Isamu Okamoto, Erina Hatashita, et al.
Cancer Science|November 12, 2022
Immunostimulatory oncolytic activity of coxsackievirus A11 in human malignant pleural mesotheliomaKoji Okamura, Hiroyuki Inoue, Kentaro Tanaka, et al.
British Journal of Cancer|July 28, 2025
Enhanced HER2 internalization by clathrin-dependent endocytosis in non-small cell lung cancer positive for HER2 mutationsAtsushi Shimauchi, Eiji Iwama, Ritsu Ibusuki, et al.
Pageof 39